Edwards Lifesciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6,068	5,440	5,010	4,464	5,233
Revenue Growth (YoY)	11.55%	8.57%	12.23%	-14.69%	19.29%
Cost of Revenue	1,334	1,118	978.4	722.1	1,249
Gross Profit	4,733	4,322	4,032	3,742	3,984
Selling, General & Admin	2,085	1,789	1,581	1,357	1,494
Research & Development	1,079	1,053	962.9	843.6	903.1
Other Operating Expenses	-67.2	-0.3	-	-	-
Operating Expenses	3,097	2,841	2,544	2,200	2,397
Operating Income	1,636	1,481	1,487	1,542	1,587
Interest Expense	-	-19.8	-17.6	-19.2	-18.4
Interest & Investment Income	148.4	120.3	67.2	35.5	17.4
Currency Exchange Gain (Loss)	-	7.1	10	1	5
Other Non Operating Income (Expenses)	7.2	6.8	3.4	-	10.8
EBT Excluding Unusual Items	1,792	1,595	1,550	1,559	1,601
Merger & Restructuring Charges	-17.4	-61	-	-62.3	-
Gain (Loss) on Sale of Investments	-	54.4	-0.7	-1.1	-2.8
Asset Writedown	-186.9	-	-	-	-
Legal Settlements	-325.4	-40.4	-203.5	-15.8	-20.6
Other Unusual Items	10.8	-	26.2	35.8	124.1
Pretax Income	1,273	1,548	1,372	1,520	1,702
Income Tax Expense	216.9	152.1	152.4	195.5	198.9
Earnings From Continuing Operations	1,056	1,396	1,220	1,324	1,503
Earnings From Discontinued Operations	13.4	2,774	179.4	197.9	-
Net Income to Company	1,069	4,170	1,399	1,522	1,503
Minority Interest in Earnings	4.1	4.9	3	-	-
Net Income	1,074	4,175	1,402	1,522	1,503
Net Income to Common	1,074	4,175	1,402	1,522	1,503
Net Income Growth	-74.28%	197.68%	-7.85%	1.25%	82.55%
Shares Outstanding (Basic)	585	598	607	619	623
Shares Outstanding (Diluted)	586	599	609	624	631
Shares Change (YoY)	-2.25%	-1.66%	-2.37%	-1.11%	-0.11%
EPS (Basic)	1.84	6.98	2.31	2.46	2.41
EPS (Diluted)	1.83	6.97	2.30	2.44	2.38
EPS Growth	-73.70%	202.39%	-5.44%	2.40%	83.08%
Free Cash Flow	-	289.9	642.8	973.6	1,406
Free Cash Flow Per Share	-	0.48	1.05	1.56	2.23
Gross Margin	78.01%	79.46%	80.47%	83.82%	76.13%
Operating Margin	26.97%	27.22%	29.69%	34.54%	30.32%
Profit Margin	17.69%	76.75%	27.99%	34.09%	28.73%
Free Cash Flow Margin	-	5.33%	12.83%	21.81%	26.88%
EBITDA	1,788	1,636	1,632	1,681	1,721
EBITDA Margin	29.47%	30.07%	32.58%	37.67%	32.90%
D&A For EBITDA	151.87	155.2	144.9	139.6	134.8
EBIT	1,636	1,481	1,487	1,542	1,587
EBIT Margin	26.97%	27.22%	29.69%	34.54%	30.32%
Effective Tax Rate	17.04%	9.83%	11.11%	12.87%	11.69%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q